Rivaroxaban use can be associated with severe and fatal spontaneous intracerebral hemorrhage, highlighting the need for caution regarding bleeding complications.
Answers are grounded in this paper and cite their sources.
Spontaneous ICH on rivaroxaban may prove fatal; case series leaves open questions on incidence and management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Debata et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: